Advertisement
Survey Series
For Advertisers
|
|
||||
|
Vax Facts
The Scientist 2004, 18(5):25
|
||||
|
|
||||
|
Cancer vaccine therapies continue to inch toward approval. Even with the complex regulations controlling biologics and cell based techniques, over 100 such treatments are undergoing clinical trials, with more than a dozen in Phase III trials. The underlying mechanisms vary widely, but they share the goal of boosting the immune system to attack pre-existing tumors. Here are four examples of formulations that have shown some promise.
|
|
|||||||||
|
|||||||||
|
